Clinical Trials on Maxillary Protraction in Class III Adolescent After Using (MSE)
Total 1 results
-
Al-Azhar UniversityActive, not recruitingMaxillary Protraction in Class III Adolescent After Using (MSE)Egypt
Sponsors and Collaborators
- Laboratoire National de Santé (LNS)
- Physicians for Social Responsibility, Finland
- Foundation for Advancing Veterans' Health Research
- Duan Li
- People's Hospital of Tibet
- Lung Clinic Heckeshorn
- ODL Terveys Oy
- Instituto Canario de Investigación del Cáncer
- EPICONCEPT
- Janny Xue Chen Ke
- SN BioScience
- Yanhong Deng
- JAMK University Of Applied Sciences
- GF Strong Rehabilitation Centre
- John Kempen
- Ministry of Trade, Industry & Energy, Republic of Korea
- Nederlandse Obesitas Kliniek
- Armando Vázquez Rangel
- NIHS
- Philip Chang
- View Full List
Medical Conditions
- Urine Incontinence
- Postural Defect
- Violence, Non-accidental
- Surgical Shock
- Relapsed or Refractory Chronic Myelomonocytic Leukemia
- Behavior Change
- Irrigated Catheters
- Lung Cancer (Non-Small Cell)
- C5 Palsy
- Stress Disorders, Traumatic
- Robot-Assisted Laparoscopic Radical Prostatectomy
- Anomalous Left Coronary Artery
- Spinal Muscular Atrophy 1
- Pulmonary Oedema
- Primary Mediastinal (Thymic) Large B-cell Lymphoma
- Concomitant Conditions
- Inflammatory Abdominal Aortic Aneurysm
- Peritoneal Mesothelioma Malignant Advanced
- Metastatic Squamous Cell Carcinoma of the Head or Neck
- Counterindicated Patients for Colonoscopy
- View Full List
Drug Interventions
- Propofol
- Mitoxantrone Hydrochloride liposome injection
- Entecavir
- Dienogest (Visanne,BAY86_5258)
- Tucatinib in Combination with Palbociclib and Letrozole
- Deferiprone
- Accordion Pill™ Carbidopa/Levodopa
- Compound lidocaine at high concentration
- Ketamine
- Methylphenidate Extended Release Capsules
- LMWH: Dalteparin
- Verelan® PM Extended-Release Capsules, 300 mg
- Dexmedetomidine
- Insulin glargine
- Copper IUD
- HCQ
- Acetylcholine 6.25, 12.5, 25 nmol/min intraarterially over 3 min/dose level (two times; pre-dose and +3.5 hrs)
- INX-08189 50 mg QD X 5 days
- Irinotecan
- Secretin (human synthetic) - ChiRhoClin
- View Full List
CROs by country
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Bangladesh
- Contract Research Organizations in Belarus
- Contract Research Organizations in Congo
- Contract Research Organizations in Estonia
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in Germany
- Contract Research Organizations in Greece
- Contract Research Organizations in Kazakhstan
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Nigeria
- CRO list by country